The Curriculum

Each SZconsult session will include a didactic session of about 15 minutes, and we’ll post the PowerPoint files and lecture recordings to the SZconsult Past Presentations blog.

Here is a list of topics we will covering in 2019.

Drop us a line to let us know what you think or if you have suggestions for additional topics.

Tuesday, January 8, 2019

What is psychosis?        

Erik Messamore, MD, PhD

Tuesday, January 15, 2019

Pharmacotypes within the schizophrenias

Erik Messamore, MD, PhD

Tuesday, January 22, 2019

Dopamine Psychosis     

Erik Messamore, MD, PhD

Tuesday, January 29, 2019

Glutamate Psychosis     

Erik Messamore, MD, PhD

Tuesday, February 5, 2019

Inflammatory Psychosis              

Erik Messamore, MD, PhD

Tuesday, February 12, 2019

Cannabis-associated Psychosis 

Erik Messamore, MD, PhD

Tuesday, February 19, 2019

Medical evaluation: Differential diagnosis and workup of schizophrenia              

Erik Messamore, MD, PhD

Tuesday, February 26, 2019

Medications that cause psychosis           

Erik Messamore, MD, PhD

Tuesday, March 5, 2019

Is psychosis neurotoxic?

Erik Messamore, MD, PhD

Tuesday, March 12, 2019

Are antipsychotic medications neurotoxic?

Erik Messamore, MD, PhD

Tuesday, March 19, 2019

Shared decision making: the best path toward medication compliance 

Erik Messamore, MD, PhD

Tuesday, March 26, 2019

Pharmacodynamics: How do antipsychotic medications work? 

Sara Dugan, PharmD, BCPP, BCPS

Tuesday, April 2, 2019

Dosing: What’s the right dose? How low can it go? How much is too much?       

Sara Dugan, PharmD, BCPP, BCPS

Tuesday, April 9, 2019

Symptom tracking in the home and clinic – ‘measurement-based care’  

Erik Messamore, MD, PhD

Tuesday, April 16, 2019

Pharmacogenetics: Can gene tests help pick the right medication?         

Sara Dugan, PharmD, BCPP, BCPS

Tuesday, April 23, 2019

What is the best medication for schizophrenia?

Sara Dugan, PharmD, BCPP, BCPS

Tuesday, April 30, 2019

Pharmacokinetics of oral antipsychotic medications      

Sara Dugan, PharmD, BCPP, BCPS

Tuesday, May 7, 2019

Pharmacokinetics of long-acting injectable medications

Sara Dugan, PharmD, BCPP, BCPS

Tuesday, May 14, 2019

Polypharmacy: When to combine medications? When not to?  

Sara Dugan, PharmD, BCPP, BCPS

Tuesday, May 21, 2019

Negative symptoms      

Erik Messamore, MD, PhD

Tuesday, May 28, 2019

Cognitive symptoms     

Erik Messamore, MD, PhD

 

Tuesday, June 4, 2019

Can we treat schizophrenia without medication side effects?

Erik Messamore, MD, PhD

Tuesday, June 11, 2019

Akathisia: A common problem with many solutions       

Erik Messamore, MD, PhD

Tuesday, June 18, 2019

Tremor, Parkinsonism, dystonia: The classical EPS           

Erik Messamore, MD, PhD

Tuesday, June 25, 2019

Metabolic adverse effects: Tips for treatment and prevention  

Sara Dugan, PharmD, BCPP, BCPS

Tuesday, July 2, 2019

Tardive dyskinesia and other tardive syndromes             

Erik Messamore, MD, PhD

Tuesday, July 9, 2019

The AIMS exam

Erik Messamore, MD, PhD

Tuesday, July 16, 2019

Sialorrhea: causes and treatment options           

Sara Dugan, PharmD, BCPP, BCPS

Tuesday, July 23, 2019

Myocarditis with antipsychotic medications      

Sara Dugan, PharmD, BCPP, BCPS

Tuesday, July 30, 2019

Thromboembolic events with antipsychotic medications             

Sara Dugan, PharmD, BCPP, BCPS

Tuesday, August 6, 2019

Anticholinergic medications: What are they good for? What are they bad for?  

Sara Dugan, PharmD, BCPP, BCPS

Tuesday, August 13, 2019

Amantadine: Uses, mechanisms of action, and side effects        

Sara Dugan, PharmD, BCPP, BCPS

Tuesday, August 20, 2019

Metformin: What psychiatric prescribers should know about it

Sara Dugan, PharmD, BCPP, BCPS

Tuesday, August 27, 2019

Lamotrigine: Reviewing the evidence relevant to schizophrenia

Sara Dugan, PharmD, BCPP, BCPS

Tuesday, September 3, 2019

Topiramate: Reviewing the evidence relevant to schizophrenia

Sara Dugan, PharmD, BCPP, BCPS

Tuesday, September 10, 2019

Lithium and the lithium-responsive schizophrenias        

Sara Dugan, PharmD, BCPP, BCPS

Tuesday, September 17, 2019

The treatment resistant patient: general approach to assessment and treatment            

Erik Messamore, MD, PhD

Tuesday, September 24, 2019

Clozapine: rationale for its use 

Erik Messamore, MD, PhD

Tuesday, October 1, 2019

Neutropenia: What is the actual risk and how can it be managed?          

Erik Messamore, MD, PhD

Tuesday, October 8, 2019

Logistics of clozapine prescribing            

Sara Dugan, PharmD, BCPP, BCPS

Tuesday, October 15, 2019

Clozapine side effects: How to prevent or manage them              

Sara Dugan, PharmD, BCPP, BCPS

Tuesday, October 22, 2019

What to do if clozapine doesn’t work?  

Erik Messamore, MD, PhD

Tuesday, October 29, 2019

A life of meaning and purpose: Minimizing disability from schizophrenia            

Erik Messamore, MD, PhD

Tuesday, November 5, 2019

Cognitive decline: Can it be prevented? Can it be reversed?       

Erik Messamore, MD, PhD

Tuesday, November 12, 2019

Psychotherapies for schizophrenia         

Erik Messamore, MD, PhD

Tuesday, November 19, 2019

Family education and support  

Erik Messamore, MD, PhD

Tuesday, November 26, 2019

Complementary, alternative, and nutritional treatments             

Erik Messamore, MD, PhD

Tuesday, December 3, 2019

Late-life psychosis         

Erik Messamore, MD, PhD

Tuesday, December 10, 2019

Childhood-onset schizophrenia

Erik Messamore, MD, PhD

Tuesday, December 17, 2019

Pregnancy, lactation and the schizophrenia patient of child-bearing potential   

Erik Messamore, MD, PhD